Prostatype Genomics AB (PROGEN)
Market Closed
15 Oct, 03:25 PM
XSTO XSTO Primary XSTO kr
0. 11
-0.01
-7.4236%
kr
- Market Cap
- P/E Ratio
- Div Yield
5.14M Volume
- Eps
kr 0.11
Previous Close Want to track PROGEN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Prostatype Genomics AB (PROGEN) Statistics
Valuation metrics
Market Cap -
Enterprise value 2.64M
Trailing P/E (ttm) -0.17
Forward P/E -
PEG ratio -0
Price/Sales (ttm) 2.99
Price/Book (mrq) 0.83
Enterprise Value/Revenue 2.6
Enterprise Value/EBITDA -0.08
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 10.26M
Average volume (90 days) 7.71M
Price summary
52-Week low 0.28
52-Week high 3.56
Beta -
50-Day moving average 0.13
200-Day moving average 0.39
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:1,000
Last split Date 31 Oct 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -37.38%
Operating margin -36.94%
Operational effectiveness
Return on assets -0.95%
Return on equity -2.29%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.64
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) 0.2
Current ratio (mrq) 0.04%
Book value per share (mrq) 0.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
